News
NTBLQ
0.0001
NaN%
--
Weekly Report: what happened at NTBLQ last week (0406-0410)?
Weekly Report · 3d ago
Weekly Report: what happened at NTBLQ last week (0330-0403)?
Weekly Report · 04/06 10:07
Weekly Report: what happened at NTBLQ last week (0323-0327)?
Weekly Report · 03/30 10:07
Weekly Report: what happened at NTBLQ last week (0316-0320)?
Weekly Report · 03/23 10:04
Weekly Report: what happened at NTBLQ last week (0309-0313)?
Weekly Report · 03/16 10:04
Weekly Report: what happened at NTBLQ last week (0302-0306)?
Weekly Report · 03/09 10:04
Weekly Report: what happened at NTBLQ last week (0223-0227)?
Weekly Report · 03/02 10:03
Weekly Report: what happened at NTBLQ last week (0216-0220)?
Weekly Report · 02/23 10:04
Weekly Report: what happened at NTBLQ last week (0209-0213)?
Weekly Report · 02/16 10:04
Weekly Report: what happened at NTBLQ last week (0202-0206)?
Weekly Report · 02/09 10:04
Weekly Report: what happened at NTBLQ last week (0126-0130)?
Weekly Report · 02/02 10:04
Weekly Report: what happened at NTBLQ last week (0119-0123)?
Weekly Report · 01/26 10:04
Weekly Report: what happened at NTBLQ last week (0112-0116)?
Weekly Report · 01/19 10:09
Weekly Report: what happened at NTBLQ last week (0105-0109)?
Weekly Report · 01/12 10:09
Weekly Report: what happened at NTBLQ last week (1229-0102)?
Weekly Report · 01/05 10:04
Weekly Report: what happened at NTBLQ last week (1222-1226)?
Weekly Report · 12/29/2025 10:03
Weekly Report: what happened at NTBLQ last week (1215-1219)?
Weekly Report · 12/22/2025 10:03
Weekly Report: what happened at NTBLQ last week (1208-1212)?
Weekly Report · 12/15/2025 10:09
Weekly Report: what happened at NTBLQ last week (1201-1205)?
Weekly Report · 12/08/2025 10:08
Weekly Report: what happened at NTBLQ last week (1124-1128)?
Weekly Report · 12/01/2025 10:04
More
Webull provides a variety of real-time NTBLQ stock news. You can receive the latest news about Notable Labs through multiple platforms. This information may help you make smarter investment decisions.
About NTBLQ
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.